Down-regulation of the antitumor immune response.
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D004731:Endotoxins / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007700:Kinetics; D051379:Mice; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology* / Q000532:radiotherapy / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000951:Antigens, Neoplasm; D004731:Endotoxins; D003520:Cyclophosphamide